Upregulated CircRNA_102231 Promotes Gastric Cancer Progression and Its Clinical Significance

Overview

Journal Bioengineered

Date 2021 Aug 10

PMID 34374630

Citations 34

Authors

Gaofeng Yuan

Wenwen Ding

Bingjie Sun

Lin Zhu

Yuewen Gao

Lulu Chen

Affiliations

Soon will be listed here.

Abstract

Circular RNAs (circRNAs) are a type of endogenous non-coding RNAs implicated in cancer progression. This study explored the expression levels, clinical implication and possible molecular mechanism of circRNA_102231 in gastric cancer (GC). Gene Expression Omnibus (GEO) was used to analyze differentially expressed circRNAs. CircRNA_102231 expression was verified by qRT-PCR in GC tissues and plasma. The effects of circRNA_102231 was tested by CCK-8, colony formation, EdU and Transwell assays and xenograft tumor model. RNA pull-down and immunoprecipitation (RIP) assays were used to analyze the interaction between circRNA_102231 and IRTKS. CircRNA_102231 expression was significantly upregulated in GC tissue and plasma samples, which can be used as a biomarker for GC diagnosis and prognosis. The function assays showed that circRNA_102231 knockdown inhibited GC cell proliferation and invasion both and . CircRNA_102231 was able to bind to IRTKS, increasing IRTKS protein stability, leading to GC progression. Overexpression of IRTKS effectively rescued the reduced cell viability and invasion caused by silencing of circRNA_102231. In sum, our data demonstrate that circRNA_102231 is a novel oncogene in GC and acts as a potential biomarker and therapeutic target for GC patients.AbbreviationscircRNAs: circular RNAs; GC: gastric cancer; GEO: Gene Expression Omnibus; RIP: RNA immunoprecipitation; DEGs: differentially expressed genes.

Citing Articles

CircMMP11 is a Potential Recurrence Biomarker and Facilitates Progression of Esophageal Squamous Cell Carcinoma.

Yuan J, Cui Y, Zhang J, Cai Y, Xu X Biochem Genet. 2025; .

PMID: 40085314 DOI: 10.1007/s10528-025-11080-9.

Exosomal circRNAs: Deciphering the novel drug resistance roles in cancer therapy.

Li X, Liu H, Xing P, Li T, Fang Y, Chen S J Pharm Anal. 2025; 15(2):101067.

PMID: 39957900 PMC: 11830318. DOI: 10.1016/j.jpha.2024.101067.

Insulin receptor tyrosine kinase substrate in health and disease (Review).

Zhang X, Zhang Z Mol Med Rep. 2025; 31(3).

PMID: 39930824 PMC: 11795247. DOI: 10.3892/mmr.2025.13437.

Non-coding RNA in the Regulation of Gastric Cancer Tumorigenesis: Focus on microRNAs and Exosomal microRNAs.

Vakilzadehian N, Moradi Y, Allela O, Al-Hussainy A, Ali Al-Nuaimi A, Kadhim A Al-Hussein R Int J Mol Cell Med. 2025; 13(4):417-435.

PMID: 39895920 PMC: 11786126. DOI: 10.22088/IJMCM.BUMS.13.4.417.

Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer.

Zhang N, Wang X, Li Y, Lu Y, Sheng C, Sun Y Commun Biol. 2025; 8(1):77.

PMID: 39825074 PMC: 11748638. DOI: 10.1038/s42003-024-07383-z.

References

Li H, Ma X, Li H . Intriguing circles: Conflicts and controversies in circular RNA research. Wiley Interdiscip Rev RNA. 2019; 10(5):e1538. DOI: 10.1002/wrna.1538. View

Du W, Zhang C, Yang W, Yong T, Awan F, Yang B . Identifying and Characterizing circRNA-Protein Interaction. Theranostics. 2017; 7(17):4183-4191. PMC: 5695005. DOI: 10.7150/thno.21299. View

Ju H, Zhao Q, Wang F, Lan P, Wang Z, Zuo Z . A circRNA signature predicts postoperative recurrence in stage II/III colon cancer. EMBO Mol Med. 2019; 11(10):e10168. PMC: 6783650. DOI: 10.15252/emmm.201810168. View

Huang L, Wang X, Cui X, Li H, Zhao J, Wu C . IRTKS is correlated with progression and survival time of patients with gastric cancer. Gut. 2017; 67(8):1400-1409. DOI: 10.1136/gutjnl-2016-313478. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Guan H, Sun C, Gu Y, Li J, Ji J, Zhu Y . Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer. Bioengineered. 2021; 12(1):2326-2340. PMC: 8806680. DOI: 10.1080/21655979.2021.1935064. View

Zou Y, Zheng S, Deng X, Yang A, Kong Y, Kohansal M . Diagnostic and prognostic value of circular RNA CDR1as/ciRS-7 for solid tumours: A systematic review and meta-analysis. J Cell Mol Med. 2020; 24(17):9507-9517. PMC: 7520288. DOI: 10.1111/jcmm.15619. View

Wilusz J . A 360° view of circular RNAs: From biogenesis to functions. Wiley Interdiscip Rev RNA. 2018; 9(4):e1478. PMC: 6002912. DOI: 10.1002/wrna.1478. View

Vo J, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y . The Landscape of Circular RNA in Cancer. Cell. 2019; 176(4):869-881.e13. PMC: 6601354. DOI: 10.1016/j.cell.2018.12.021. View

10.

Huang A, Zheng H, Wu Z, Chen M, Huang Y . Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020; 10(8):3503-3517. PMC: 7069073. DOI: 10.7150/thno.42174. View

11.

Chen C, Hsu J, Wu D, Kang W, Hsieh J, Jaw T . Gastric cancer: preoperative local staging with 3D multi-detector row CT--correlation with surgical and histopathologic results. Radiology. 2007; 242(2):472-82. DOI: 10.1148/radiol.2422051557. View

12.

Salzman J . Circular RNA Expression: Its Potential Regulation and Function. Trends Genet. 2016; 32(5):309-316. PMC: 4948998. DOI: 10.1016/j.tig.2016.03.002. View

13.

Zhang X, Hu Z, Li W, Liu Z, Li J, Wang Z . Circular RNA 0102049 suppresses the progression of osteosarcoma through modulating miR-520g-3p/PLK2 axis. Bioengineered. 2021; 12(1):2022-2032. PMC: 8806202. DOI: 10.1080/21655979.2021.1923259. View

14.

Smyth E, Nilsson M, Grabsch H, van Grieken N, Lordick F . Gastric cancer. Lancet. 2020; 396(10251):635-648. DOI: 10.1016/S0140-6736(20)31288-5. View

15.

Du W, Yang W, Li X, Awan F, Yang Z, Fang L . A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy. Oncogene. 2018; 37(44):5829-5842. DOI: 10.1038/s41388-018-0369-y. View

16.

Gao C, Wen Y, Jiang F, Gu X, Zhu X . Circular RNA circ_0008274 upregulates granulin to promote the progression of hepatocellular carcinoma via sponging microRNA -140-3p. Bioengineered. 2021; 12(1):1890-1901. PMC: 8806606. DOI: 10.1080/21655979.2021.1926195. View

17.

Yang Z, Xie L, Han L, Qu X, Yang Y, Zhang Y . Circular RNAs: Regulators of Cancer-Related Signaling Pathways and Potential Diagnostic Biomarkers for Human Cancers. Theranostics. 2017; 7(12):3106-3117. PMC: 5566109. DOI: 10.7150/thno.19016. View

18.

Tang L, Xiong W, Zhang L, Wang D, Wang Y, Wu Y . circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma. Oncogene. 2020; 40(2):307-321. DOI: 10.1038/s41388-020-01531-5. View

19.

Baretton G, Aust D . [Current biomarkers for gastric cancer]. Pathologe. 2017; 38(2):93-97. DOI: 10.1007/s00292-017-0271-3. View

20.

Zhong W, Bao L, Yuan Y, Meng Y . CircRASSF2 acts as a prognostic factor and promotes breast cancer progression by modulating miR-1205/HOXA1 axis. Bioengineered. 2021; 12(1):3014-3028. PMC: 8806576. DOI: 10.1080/21655979.2021.1933300. View